{"transactions":[{"id":2838099,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":142306,"kind":"person","name":"Donaldson Michael Paul","position":1,"cik":"0001824022","reported_name":"Donaldson Michael Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-23T22:59:25.000Z","date":"2021-02-19","kind":"disposition_to_issuer","acquired":false,"shares":5110,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the forfeiture of performance-based stock options granted to the Reporting Person on June 8, 2020 that were eligible to vest based on certain performance conditions. Upon grant, the target vesting amount was reported in Table II of Form 3. On February 19, 2021, the Compensation Committee of the Board of Directors of the Issuer determined that, based on the Issuer's performance over the applicable performance period, 37,129 shares would vest and 5,110 shares would be forfeited."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of February 19, 2021, a total of 79,368 shares have vested and 515,522 shares remain eligible to vest from this grant."}],"balance_after":594890,"derivative":{"exercise_price":3.52,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":5110},"source":{"system":"sec-edgar","filing":"0000921895-21-000543","document":"form412566don_02232021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000092189521000543/form412566don_02232021.xml","form_type":"4"}}]}